Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34810
Title: Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome
Other Titles: Hepatotoxicidad asociada con eculizumab en un paciente con síndrome urémico hemolítico atípico
Authors: Aktaş, Nimet
Uludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.
0000-0002-0342-9692
0000-0003-4607-9220
Oruç, Ayşegül
Ayar, Yavuz
Vuruşkan, Berna Aytaç
Yıldız, Abdülmecit
Yavuz, Mahmut
Güllülü, Mustafa
Dilek, Kamil
Ersoy, Alparslan
AAH-4002-2021
O-9948-2015
AAH-9746-2021
AGF-0767-2022
GSE-0029-2022
55133912100
55860143300
56527372000
56256977500
7006244754
6602684544
56005080200
35612977100
Keywords: Urology & nephrology
Complement inhibitor eculizumab
Issue Date: 2018
Publisher: Soc Espanola Nefrologia Dr Rafael Matesanz
Citation: Oruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450.
URI: https://doi.org/10.1016/j.nefroe.2018.04.004
https://www.sciencedirect.com/science/article/pii/S2013251418300622
http://hdl.handle.net/11452/34810
ISSN: 0211-6995
1989-2284
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Oruç_vd_2018.pdf540.59 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons